| Variables§ . | Healthy controls (n = 34) . | Responders (n = 36) . | Non-responders (n = 33) . | p . |
|---|---|---|---|---|
| Age (yr) | 64.0 (61.0–67.0) | 64.5 (61.5–69.0) | 66.0 (59.0–71.0) | 1.000$ |
| Gender (M/F) | 15/19 | 10/26 | 10/23 | 0.910& |
| Family history (P/A) | 4/32 | 5/28 | 0.728# | |
| Onset age (yr) | 58.5 (51.0–63.0) | 57.0 (53.0–67.0) | 0.847* | |
| Episode no. | 2.00 (1.00–3.00) | 2.00 (1.00–2.00) | 0.858* | |
| Duration of current episode (months) | 3.50 (1.00–11.0) | 4.00 (2.00–8.00) | 0.933* | |
| Baseline HAMD score | 18.5 (16.0–22.0) | 20.0 (17.0–21.0) | 0.422* |
| Variables§ . | Healthy controls (n = 34) . | Responders (n = 36) . | Non-responders (n = 33) . | p . |
|---|---|---|---|---|
| Age (yr) | 64.0 (61.0–67.0) | 64.5 (61.5–69.0) | 66.0 (59.0–71.0) | 1.000$ |
| Gender (M/F) | 15/19 | 10/26 | 10/23 | 0.910& |
| Family history (P/A) | 4/32 | 5/28 | 0.728# | |
| Onset age (yr) | 58.5 (51.0–63.0) | 57.0 (53.0–67.0) | 0.847* | |
| Episode no. | 2.00 (1.00–3.00) | 2.00 (1.00–2.00) | 0.858* | |
| Duration of current episode (months) | 3.50 (1.00–11.0) | 4.00 (2.00–8.00) | 0.933* | |
| Baseline HAMD score | 18.5 (16.0–22.0) | 20.0 (17.0–21.0) | 0.422* |
SSRI, Selective serotonin reuptake inhibitor; M/F, Males/Females; P/A, presence/absence; Episode no., lifetime number including current episode; Duration of current episode, duration months of current episode; HAMD, Hamilton Rating Scale for Depression.
Values are shown as median (25–75% interquartile range).
Kruskal–Wallis test, corrected p.
χ2 test, corrected p.
Fisher's exact test.
Mann–Whitney test.
| Variables§ . | Healthy controls (n = 34) . | Responders (n = 36) . | Non-responders (n = 33) . | p . |
|---|---|---|---|---|
| Age (yr) | 64.0 (61.0–67.0) | 64.5 (61.5–69.0) | 66.0 (59.0–71.0) | 1.000$ |
| Gender (M/F) | 15/19 | 10/26 | 10/23 | 0.910& |
| Family history (P/A) | 4/32 | 5/28 | 0.728# | |
| Onset age (yr) | 58.5 (51.0–63.0) | 57.0 (53.0–67.0) | 0.847* | |
| Episode no. | 2.00 (1.00–3.00) | 2.00 (1.00–2.00) | 0.858* | |
| Duration of current episode (months) | 3.50 (1.00–11.0) | 4.00 (2.00–8.00) | 0.933* | |
| Baseline HAMD score | 18.5 (16.0–22.0) | 20.0 (17.0–21.0) | 0.422* |
| Variables§ . | Healthy controls (n = 34) . | Responders (n = 36) . | Non-responders (n = 33) . | p . |
|---|---|---|---|---|
| Age (yr) | 64.0 (61.0–67.0) | 64.5 (61.5–69.0) | 66.0 (59.0–71.0) | 1.000$ |
| Gender (M/F) | 15/19 | 10/26 | 10/23 | 0.910& |
| Family history (P/A) | 4/32 | 5/28 | 0.728# | |
| Onset age (yr) | 58.5 (51.0–63.0) | 57.0 (53.0–67.0) | 0.847* | |
| Episode no. | 2.00 (1.00–3.00) | 2.00 (1.00–2.00) | 0.858* | |
| Duration of current episode (months) | 3.50 (1.00–11.0) | 4.00 (2.00–8.00) | 0.933* | |
| Baseline HAMD score | 18.5 (16.0–22.0) | 20.0 (17.0–21.0) | 0.422* |
SSRI, Selective serotonin reuptake inhibitor; M/F, Males/Females; P/A, presence/absence; Episode no., lifetime number including current episode; Duration of current episode, duration months of current episode; HAMD, Hamilton Rating Scale for Depression.
Values are shown as median (25–75% interquartile range).
Kruskal–Wallis test, corrected p.
χ2 test, corrected p.
Fisher's exact test.
Mann–Whitney test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
